← Back
Karman Holdings
KRMN · listed on the New York Stock Exchange · worth $5.19 billion
$39.13
−2.05% on Nov 2
Three insider buys in the last year, $1.04 million in all. None in the last two weeks.
Different buyers at once3 insiders bought, and BlackRock reported a new 11.1% stake, within 3 weeks · Oct 5
Green dot = an insider bought red = sold◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
102.6M shares
77% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, three insiders bought Karman Holdings stock and five insiders sold. None of the 8 sales is marked on its filing as planned in advance; most by company executives. The biggest seller was Anthony Koblinski, Chief Executive Officer.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
Director
David Stinnett
Bought $1.01M on Sep 16 — 27,000 shares at $37.32, 0.8% of what they now own.
No earlier purchases to measure
Director
Mary D. Petryszyn
Bought $18.7K on Sep 16 — 500 shares at $37.44, 18% of what they now own.
No earlier purchases to measure
Director
Stephen Twitty
Bought $10.1K on Sep 16 — 275 shares at $36.79, 10% of what they now own.
No earlier purchases to measure
Big investors
People and funds that reported owning 5% or more of Karman Holdings, newest first.
All reports
Every insider trade and SEC report we hold for Karman Holdings.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Dec 15, 2025SoldAnthony KoblinskiDec 15, 2025 · Traded Dec 12, 2025 · Chief Executive Officervia a trust or family75,000 @ $69.31$5.2M
Dec 8, 2025SoldAnthony KoblinskiDec 8, 2025 · Traded Dec 5, 2025 · Chief Executive Officervia a trust or family75,000 @ $66.51$4.99M
12 more with Pro →Analysts, earnings and news
Analysts' price target
$103.50 average
10 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
1 of 3 quarters above
Q4 '25$0.11 a share−$0.00
Q3 '25$0.10 a share−$0.01
Q2 '25$0.10 a share+$0.03